港股異動 | 藥品股普漲 三生製藥(1530.HK)升逾5%領漲
格隆匯1月9日丨藥品股普漲,三生製藥(1530.HK)升5.81%領漲,泰凌醫藥漲逾4%,翰森製藥、四環醫藥、同仁堂科技漲逾3%,中生製藥、中國中藥等漲逾2%。個股方面,三生製藥日前獲JP Morgan增持270.3萬股;此前12月底發公告稱,擬購回最多約2.53億股股份,佔於股東周年大會日期已發行股份總數10%。中生製藥昨晚公告稱,研製的預防化療引起的噁心嘔吐藥注射用福沙匹坦獲歐盟藥品上市許可。 板塊方面,中信建投稱,展望2020年,看好醫藥行業的結構性投資機會2.0版,建議堅定持有核心資產,同時積極關注具備性價比優勢的細分龍頭。醫藥板塊近期表現平淡,認為目前是很好的醫藥佈局的時間點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.